[go: up one dir, main page]

EP0670734A4 - SUB-POPULATION OF Mac-1 MOLECULES (CD11B / CD 18) THAT INDUCE NEUTROPHILIC ADHESION TO ICAM-1 AND FIBRINOGEN. - Google Patents

SUB-POPULATION OF Mac-1 MOLECULES (CD11B / CD 18) THAT INDUCE NEUTROPHILIC ADHESION TO ICAM-1 AND FIBRINOGEN.

Info

Publication number
EP0670734A4
EP0670734A4 EP93924919A EP93924919A EP0670734A4 EP 0670734 A4 EP0670734 A4 EP 0670734A4 EP 93924919 A EP93924919 A EP 93924919A EP 93924919 A EP93924919 A EP 93924919A EP 0670734 A4 EP0670734 A4 EP 0670734A4
Authority
EP
European Patent Office
Prior art keywords
cd11b
icam
fibrinogen
mac
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93924919A
Other languages
German (de)
French (fr)
Other versions
EP0670734A1 (en
Inventor
Michael Diamond
Timothy A Springer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Immune Disease Institute Inc
Center for Blood Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Disease Institute Inc, Center for Blood Research Inc filed Critical Immune Disease Institute Inc
Publication of EP0670734A1 publication Critical patent/EP0670734A1/en
Publication of EP0670734A4 publication Critical patent/EP0670734A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP93924919A 1992-10-09 1993-10-12 SUB-POPULATION OF Mac-1 MOLECULES (CD11B / CD 18) THAT INDUCE NEUTROPHILIC ADHESION TO ICAM-1 AND FIBRINOGEN. Withdrawn EP0670734A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95890492A 1992-10-09 1992-10-09
US958904 1992-10-09
US96415692A 1992-10-22 1992-10-22
US964156 1992-10-22
PCT/US1993/009777 WO1994008620A1 (en) 1992-10-09 1993-10-12 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen

Publications (2)

Publication Number Publication Date
EP0670734A1 EP0670734A1 (en) 1995-09-13
EP0670734A4 true EP0670734A4 (en) 1998-01-14

Family

ID=27130401

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93924919A Withdrawn EP0670734A4 (en) 1992-10-09 1993-10-12 SUB-POPULATION OF Mac-1 MOLECULES (CD11B / CD 18) THAT INDUCE NEUTROPHILIC ADHESION TO ICAM-1 AND FIBRINOGEN.

Country Status (5)

Country Link
EP (1) EP0670734A4 (en)
JP (1) JPH08502956A (en)
AU (1) AU674556B2 (en)
CA (1) CA2144738A1 (en)
WO (1) WO1994008620A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ295352A (en) * 1994-10-25 1999-09-29 Glaxo Group Ltd Use of binding agents like antibodies for inhibiting cd23 in treating prophylaxis of autoimmune diseases
NL1001380C2 (en) * 1995-10-09 1997-04-11 Fuji Photo Film Bv Method of dispersing an oil droplet type emulsified material in a liquid supply system and coating method using such a dispersing method.
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
US20020081294A1 (en) 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
WO2007048186A1 (en) * 2005-10-25 2007-05-03 Baker Medical Research Institute Leukocyte-binding polypeptides and uses thereof
WO2010017083A1 (en) * 2008-08-04 2010-02-11 Wayne State University Methods of treating cancer with cd11b antibodies
KR20140068877A (en) 2011-08-17 2014-06-09 제넨테크, 인크. Inhibition of angiogenesis in refractory tumors
US20150337039A1 (en) * 2014-05-22 2015-11-26 Case Western Reserve University Mac-1 antibodies and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009672A1 (en) * 1987-06-11 1988-12-15 The University Of Michigan Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
WO1989000190A1 (en) * 1987-07-06 1989-01-12 Dana-Farber Cancer Institute Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
EP0364690A2 (en) * 1988-08-23 1990-04-25 Dana Farber Cancer Institute The alpha-subunit of the Mac-1 leukocyte adhesion receptor
EP0488061A2 (en) * 1990-11-28 1992-06-03 Center For Blood Research Laboratories, Inc. The MAC-1 binding site of ICAM-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2976381B2 (en) * 1988-09-28 1999-11-10 ダナ ファーバー キャンサー インスティテュート Intercellular adhesion molecule and its binding ligand

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009672A1 (en) * 1987-06-11 1988-12-15 The University Of Michigan Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
WO1989000190A1 (en) * 1987-07-06 1989-01-12 Dana-Farber Cancer Institute Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
EP0364690A2 (en) * 1988-08-23 1990-04-25 Dana Farber Cancer Institute The alpha-subunit of the Mac-1 leukocyte adhesion receptor
EP0488061A2 (en) * 1990-11-28 1992-06-03 Center For Blood Research Laboratories, Inc. The MAC-1 binding site of ICAM-1

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
BROWN E J ET AL: "Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac - 1 antigen.", JOURNAL OF CLINICAL INVESTIGATION, (1988 FEB) 81 (2) 365-75. JOURNAL CODE: HS7. ISSN: 0021-9738., United States, XP002094276 *
COLLET B ET AL: "Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac - 1 antigen.", CANCER IMMUNOLOGY, IMMUNOTHERAPY, (1988) 26 (3) 237-42. JOURNAL CODE: CN3. ISSN: 0340-7004., GERMANY, WEST: Germany, Federal Republic of, XP002094277 *
DANA N ET AL: "Two functional domains in the phagocyte membrane glycoprotein MO1 identified with monoclonal antibodies", JOURNAL OF IMMUNOLOGY, vol. 137, no. 10, 15 November 1986 (1986-11-15), pages 3259 - 3263, XP000655020 *
DIAMOND M S ET AL: "A Subpopulation of MAC-1 (CD11B/CD18) Molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen", JOURNAL OF CELL BIOLOGY, vol. 120, no. 2, January 1993 (1993-01-01), pages 545 - 556, XP000655147 *
DIAMOND M S ET AL: "The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b /CD18) for four distinct adhesion ligands.", JOURNAL OF CELL BIOLOGY, (1993 FEB) 120 (4) 1031-43. JOURNAL CODE: HMV. ISSN: 0021-9525., United States, XP002094281 *
DING A ET AL: "Activation of mouse peritoneal macrophages by monoclonal antibodies to Mac - 1 (complement receptor type 3).", JOURNAL OF EXPERIMENTAL MEDICINE, (1987 MAR 1) 165 (3) 733-49. JOURNAL CODE: I2V. ISSN: 0022-1007., United States, XP002094278 *
ELEMER G ET AL: "Monoclonal antibody 7A10 defines a functional neoepitope of the leukocyte integrin CD11B-CD18 MAC - 1", 1992 MEETING OF THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY (FASEB), PART II, ANAHEIM, CALIFORNIA, USA, APRIL 5-9, 1992. FASE (FED AM SOC EXP BIOL) J. (1992) 6 (5), A1893. CODEN: FAJOEC. ISSN: 0892-6638., XP002094274 *
KISHIMOTO ET AL.: "The leukocyte integrins", ADVANCES IN IMMUNOLOGY, vol. 46, 1989, pages 149 - 182, XP000655002 *
LUK, JOHN ET AL: "Subunit specificity and epitope mapping of Mac-1 and p150,95 mAb using chimeric CD11b X CD11c transfectants", LEUCOCYTE TYPING V: WHITE CELL DIFFER. ANTIGENS, PROC. INT. WORKSHOP CONF., 5TH (1995), MEETING DATE 1993, VOLUME 2, 1599-1601. EDITOR(S): SCHLOSSMAN, STUART F. PUBLISHER: OXFORD UNIVERSITY PRESS, OXFORD, UK. CODEN: 63WDAC, XP002094280 *
SCHEINBERG D A: "Current applications of monoclonal antibodies for the therapy of hematopoietic cancers.", CURRENT OPINION IN IMMUNOLOGY, (1991 OCT) 3 (5) 679-84. REF: 47 JOURNAL CODE: AH1. ISSN: 0952-7915., ENGLAND: United Kingdom, XP002094279 *
See also references of WO9408620A1 *
SPRINGER T ET AL: "Mac - 1: a macrophage differentiation antigen identified by monoclonal antibody.", EUROPEAN JOURNAL OF IMMUNOLOGY, (1979 APR) 9 (4) 301-6. JOURNAL CODE: EN5. ISSN: 0014-2980., GERMANY, WEST: Germany, Federal Republic of, XP002094275 *

Also Published As

Publication number Publication date
WO1994008620A1 (en) 1994-04-28
AU674556B2 (en) 1997-01-02
JPH08502956A (en) 1996-04-02
EP0670734A1 (en) 1995-09-13
CA2144738A1 (en) 1994-04-28
AU5442394A (en) 1994-05-09

Similar Documents

Publication Publication Date Title
DE69422351D1 (en) Particle analysis of notched disks
DE69333929D1 (en) CONJUGATES OF ALGINATE AND BIOACTIVE AGENTS
FI961015L (en) Separation of liquid and solid components
DE69729639D1 (en) SYSTEM FOR VASCULAR CANALATION OF STENOTIC BYPASS TRANSPLANTS AND OTHER BLOOD VESSELS
KR870700359A (en) Vascular formation factors and vasculature
DK531887D0 (en) MUTAGENESE AND SCREENING PROCEDURE AND PRODUCT
BR9301417A (en) NIQUEL-MOLIBDENIO AUSTENTIC ALLOY AND ITS APPLICATION
DE19680256T1 (en) Small inhibitor molecules of the enzyme activity of rotamase
FR2611777B1 (en) PERFORATED SOUND ABSORPTION PANEL
EG20455A (en) Optically active derivatives of 2-imidazoline-5-ones and 2-imidazolines-5-thiones fungicides
EP0635029A4 (en) CARTILAGE MATRIX PROTEIN AND METHODS OF USE.
IT8421972A0 (en) CAVERTER WHEEL WITH MEANS OF STOPPING AND RESUMMING ADJUSTABILITY.
DE68929060D1 (en) Synthesis of 1,2-dioxetanes and intermediates therefor
FR2564225B1 (en) DISPLAY DEVICE WITH INCLINED DISC AXLE
DE69016304D1 (en) Agglomeration of particles.
DE68909466D1 (en) INTERACTION OF PROMOTORS IN PENTENNITRILE HYDROCYANING.
EP0670734A4 (en) SUB-POPULATION OF Mac-1 MOLECULES (CD11B / CD 18) THAT INDUCE NEUTROPHILIC ADHESION TO ICAM-1 AND FIBRINOGEN.
EP0708639A4 (en) METHODS AND COMPOSITIONS FOR TREATING DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (+)
BE891319A (en) ELECTRODEPOSITION OF PALLADIUM AND PALLADIUM ALLOYS
FR2738997B1 (en) METHOD OF ASSEMBLING SEALED AND FIRE-RESISTANT FABRIC PIECES AND COMBINATION CARRIED OUT THEREBY
IT8820990A0 (en) PENEM ESTERS 6 REPLACED AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS.
ITMI931175A0 (en) POLYSACCHARIDES WITH HIGH ANTITHROMBOTIC AND ANTICOAGULANT ACTIVITY
FR2627905B1 (en) WELDING AND SUPPORT RING
FI915671A7 (en) Liquid enzyme concentrate
FR2577780B1 (en) FRAME DEVICE, ELEMENTS CONTAINING THE SAME, AND FRAME THUS PRODUCED

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950407

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19971128

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

DA4 Supplementary search report drawn up and despatched (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 19990318

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000501